Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 58,451 | 37,788 | 38,521 |
| Marketable Securities | 177,431 | 109,750 | N/A |
| TOTAL | $241,419 | $150,993 | $39,207 |
| Non-Current Assets | |||
| PPE Net | 2,225 | 2,466 | 3,107 |
| Investments And Advances | 74,420 | 20,505 | 0 |
| Other Non-Current Assets | 7,889 | 11,788 | 9,631 |
| TOTAL | $84,534 | $34,759 | $12,738 |
| Total Assets | $325,953 | $185,752 | $51,945 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 769 | 1,186 | 719 |
| Accrued Expenses | 9,668 | 8,162 | 6,590 |
| Other current liabilities | 6 | N/A | N/A |
| TOTAL | $11,712 | $10,420 | $8,037 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 7,408 | 339,045 | 158,789 |
| TOTAL | $7,408 | $339,045 | $158,789 |
| Total Liabilities | $19,120 | $349,465 | $166,826 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 44,998 | N/A | N/A |
| Common Shares | 45 | 5 | 2 |
| Retained earnings | -256,354 | -181,086 | -119,398 |
| Other shareholders' equity | 540 | 368 | 0 |
| TOTAL | $306,833 | $-163,713 | $-114,881 |
| Total Liabilities And Equity | $325,953 | $185,752 | $51,945 |